Tumor‐derived VEGF‐C/VEGFR‐3 signaling drives lymphangiogenesis by activating LECs, while VEGFR1+ hematopoietic bone marrow progenitors colonize premetastatic sites to secrete prolymphangiogenic factors, priming the niche for metastasis [136]. Here, FLT1 is linked to neoplasm.